CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cullinan Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$13.98+1.05 (+8.12%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Cullinan Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 1, 2026 | Oct 2, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 24, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 13, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 27, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2025 | Sep 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 24, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2025 | Jan 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2024 | Oct 16, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2024 | Sep 17, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2024 | Jun 3, 2024 | SEC EDGAR |